Charles Brandes's position in Novartis AG is currently worth $23.1 Million. That's 0.27% of their equity portfolio (88th largest holding). The first Novartis AG trade was made in Q4 2020. Since then Charles Brandes bought shares eight more times and sold shares on eight occasions. The stake costed the investor $18.9 Million, netting the investor a gain of 22% so far.